A prospective interventional randomized study to assess efficacy of angiotensin receptor neprilysin inhibitor in right ventricular systolic dysfunction with normal left ventricular systolic function.
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: Chronic heart failure - treatment 7
